Drug Industry Concept

Vocabulary Service

MeSH

Overview

subject area of

A Prospective Before-and-After Trial of an Educational Intervention about Pharmaceutical Marketing Academic Article
Academic medicine and the pharmaceutical industry: a cautionary tale. Academic Article
Accounting for reasonableness: Exploring the personal internal framework affecting decisions about cancer drug funding Academic Article
Agreements between industry and academia on publication rights: A retrospective study of protocols and publications of randomized clinical trials Academic Article
Antileukotrienes, asthma pathogenesis and the pharmaceutical industry. Academic Article
Assessing the quality of drug detailing Academic Article
Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Academic Article
Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis Academic Article
Awareness and attitudes of the Lebanese population with regard to physician–pharmaceutical company interaction: a survey study Academic Article
BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles Academic Article
Balancing quality and cost: a public decision-making process. Academic Article
Bill C-91: the debate continues. Academic Article
Canada’s New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem Academic Article
Canada’s laws on pharmaceutical intellectual property: the case for fundamental reform: Figure 1: Academic Article
Clinical experts or methodologists to write clinical guidelines? Academic Article
Combination Therapy to Prevent Cardiovascular Disease Academic Article
DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS Academic Article
DTCA in New Zealand: the challenge of finding an acceptable balance. Academic Article
Determining an ethical stance. Pharmaceutical industry involvement and family medicine residency training. Academic Article
Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods Academic Article
Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor Academic Article
Development of a standardized, comprehensive "ideal drug detail". Academic Article
Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont. Academic Article
Direct to consumer advertising Academic Article
Disappearing Acts: Anguish, Isolation, and the Re-imagining of the Mentally Ill in Global Psychopharmaceutical Advertising (1953–2005) Academic Article
Do editors live up to the Sept 10, 2001, expectations? Academic Article
Doctors must be trained to assess credibility Academic Article
Drug Development: From Concept to Marketing! Academic Article
Effect of Pressure on Molecular and Ionic Motions in Ultraviscous Acetaminophen–Aspirin Mixture Academic Article
Extent of physician–pharmaceutical industry interactions in low-and middle-income countries: a systematic review Academic Article
Factors associated with drug shortages in Canada: a retrospective cohort study Academic Article
Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials Academic Article
Financial relationships between patient and consumer representatives and the health industry: A systematic review Academic Article
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery Academic Article
GRADE guidelines: 5. Rating the quality of evidence—publication bias Academic Article
Healing an ailing pharmaceutical system: prescription for reform for United States and Canada Academic Article
Health sciences and the pharmaceutical industry: partnerships can be effective and ethical. Academic Article
How should we support pharmaceutical innovation? Academic Article
Improving Cancer Outcomes Through International Collaboration in Academic Cancer Treatment Trials Academic Article
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model Academic Article
Industry funded patient information and the slippery slope to New Zealand Academic Article
Integrating medication samples into the traditional community pharmacy supply chain: a feasibility study Academic Article
Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. - PubMed - NCBI Article
Investigator-initiated trials are more impartial Academic Article
Is the GAIN Act a turning point in new antibiotic discovery? Academic Article
Knowledge, beliefs and attitudes of patients and the general public towards the interactions of physicians with the pharmaceutical and the device industry: a systematic review Academic Article
Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review Academic Article
LETTERS TO THE EDITOR Academic Article
Legislative, educational, policy and other interventions targeting physicians’ interaction with pharmaceutical companies: a systematic review Academic Article
Managing drug shortages during a pandemic: tocilizumab and COVID-19 Academic Article
Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. Academic Article
New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit? Academic Article
New approaches to rewarding pharmaceutical innovation Academic Article
New drug development Academic Article
No free lunch. Academic Article
Novel approaches to discovery of antibacterial agents Academic Article
Optimal Global Value of Information Trials: Better Aligning Manufacturer and Decision Maker Interests and Enabling Feasible Risk Sharing Academic Article
Optimal sample size determinations from an industry perspective based on the expected value of information Academic Article
Oral anticoagulant therapy. Urgent need for standardization. Academic Article
Pediatric drug data in Canadian drug monographs: a descriptive analysis Academic Article
Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows. Academic Article
Response to Maubach and Hoek's paper on GP attitudes to DTCA. Academic Article
Revitalizing Pharmaceutical Innovation For Global Health Academic Article
SSRI treatment for under-18s Academic Article
Sir William Osler (1849-1919): His Opinion of Modern Therapeutics Academic Article
Something old, something new: revisiting natural products in antibiotic drug discovery Academic Article
Stakeholder Involvement: How to Do It Right Academic Article
Stakeholders’ feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines Academic Article
Stopping a trial early in oncology: for patients or for industry? Academic Article
The Impact of Drug Vintage on Patient Survival: A Patient-Level Analysis Using Quebec's Provincial Health Plan Data Academic Article
The Impact of Tiered-Pricing Framework on Generic Entry in Canada Academic Article
The NICE Reference Case Requirement Academic Article
The Opportunity Cost of Capital Academic Article
The Process Analytical Technology initiative and multivariate process analysis, monitoring and control Academic Article
The Self-Perceived Role and Educational Needs of Pharmaceutical Representatives: A Survey Academic Article
The art and science of marketing medications. Academic Article
The cost of drug development: A systematic review Academic Article
The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand. 'Possums in the headlights?'. Academic Article
The shipwreck of the singular Academic Article
Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP Compliance Academic Article
Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately? Academic Article
Validity of tools used for surveying physicians about their interactions with pharmaceutical company: a systematic review Academic Article
Value of Information and Pricing New Healthcare Interventions Academic Article
Value-based arrangements may be more prevalent than assumed Academic Article
What do Canadians think about physician–pharmaceutical industry interactions? Academic Article
When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing Academic Article
Why West Africa rejected donation of Chinese medicine for treating Ebola recommended by Chinese government? Academic Article
“A magical little pill that will relieve you of your womanly issues”: What young women say about menstrual suppression Academic Article